02/29/2024 6:31 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 8:41 AM | Arbutus Biopharma (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
02/05/2024 6:54 PM | Arbutus Biopharma (Issuer) McElhaugh Michael J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 6:54 PM | Arbutus Biopharma (Issuer) Sofia Michael J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 6:54 PM | Arbutus Biopharma (Issuer) HASTINGS DAVID C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 6:55 PM | Arbutus Biopharma (Issuer) Sims Karen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 6:55 PM | Arbutus Biopharma (Issuer) Naftzger J. Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
01/08/2024 6:31 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:09 PM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2023 7:00 AM | Arbutus Biopharma (Subject) Two Seas Capital LP (Filed by)
| Form SC 13G | |
11/07/2023 3:18 PM | Arbutus Biopharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023 6:31 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 6:16 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2023 7:06 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 4:07 PM | Arbutus Biopharma (Subject) Whitefort Capital Management, LP (Filed by)
| Form SC 13G | |
09/11/2023 3:16 PM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 6:31 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/13/2023 3:11 PM | Arbutus Biopharma (Issuer) Rewolinski Melissa (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/13/2023 3:13 PM | Arbutus Biopharma (Issuer) Rewolinski Melissa (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 3:48 PM | Arbutus Biopharma (Issuer) Sims Karen (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/12/2023 3:50 PM | Arbutus Biopharma (Issuer) Sims Karen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 3:10 PM | Arbutus Biopharma (Issuer) Naftzger J. Christopher (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/12/2023 3:12 PM | Arbutus Biopharma (Issuer) Naftzger J. Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 6:31 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2023 3:02 PM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2023 6:31 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2023 5:10 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2023 5:00 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/26/2023 3:22 PM | Arbutus Biopharma (Issuer) BURGESS DANIEL D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 3:27 PM | Arbutus Biopharma (Issuer) HENRIQUES RICHARD C JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 3:07 PM | Arbutus Biopharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023 6:32 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/27/2023 5:00 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2023 6:31 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2023 7:00 AM | Arbutus Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |